-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GiuESc912tIKNVxuVJCKmonTL6b8Xgl4ef86sCQlj3kyJUqlpJtKRwlD6h1mnhJv BwPQqpMInNgiyR+jdHi8TQ== 0000929638-01-500194.txt : 20010917 0000929638-01-500194.hdr.sgml : 20010917 ACCESSION NUMBER: 0000929638-01-500194 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20010914 GROUP MEMBERS: AIM HIGH ENTERPRISES, INC. GROUP MEMBERS: KAIROS PARTNERS GP, LLC GROUP MEMBERS: KAIROS PARTNERS, LP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-37473 FILM NUMBER: 1737514 BUSINESS ADDRESS: STREET 1: 3130 GATWAY STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 7704412051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091-5625 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KAIROS PARTNERS LP CENTRAL INDEX KEY: 0001122689 STANDARD INDUSTRIAL CLASSIFICATION: [] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 600 LONGWATER DRIVE STREET 2: SUITE 204 CITY: NORWELL STATE: MA ZIP: 02061 BUSINESS PHONE: 7816351100X1123 MAIL ADDRESS: STREET 1: 600 LONGWATER DR. STREET 2: SUITE 204 CITY: NORWELL STATE: MA ZIP: 02061 SC 13D/A 1 a1036363.txt AMENDMENT NO. 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (RULE 13D-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13D-1(A) AND AMENDMENTS THERETO FILED PURSUANT TO 13D-2(A) (AMENDMENT NO. 7)* Immucor, Inc. (Name of Issuer) Common Stock, $.10 par value (Title of Class of Securities) 452526106 (CUSIP Number) James F. Rice, Managing Director c/o Aim High Enterprises, Inc. 600 Longwater Drive, Suite 204 Norwell, MA 02061 (781) 635-1121 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) September 7, 2001 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box //. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. (Continued on the following pages) (Page 1 of 9 Pages) - ---------------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 452526106 13D/A PAGE 2 OF 8
- ------ ------------------------------------------------------------------------ 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Kairos Partners, LP (Tax ID: 04-3521249) Kairos Partners GP, LLC Aim High Enterprises, Inc. - ------ ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) // (B) x - ------ ------------------------------------------------------------------------ 3 SEC USE ONLY - ------ ------------------------------------------------------------------------ 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC--SEE ITEM 3 - ------ ------------------------------------------------------------------------ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) // ( - ------ ------------------------------------------------------------------------ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Kairos Partners, LP is a Delaware limited partnership. Kairos Partners GP,LLC is a Delaware limited liability corporation. Aim High Enterprises, Inc. is a Delaware corporation. - ------ ------------------------------------------------------------------------ 7 SOLE VOTING POWER None NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH -------- -------------------------------------------- 8 SHARED VOTING POWER 819,770 shares--See Item 5 -------- -------------------------------------------- 9 SOLE DISPOSITIVE POWER None -------- -------------------------------------------- 10 SHARED DISPOSITIVE POWER 819,770 shares--See Item 5 - ------ ------------------------------------------------------------------------ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 819,770 shares--See Item 5 - ------ ------------------------------------------------------------------------ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) // Not Applicable. - ------ ------------------------------------------------------------------------ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 11.3% (based on 7,277,617 shares of Common Stock outstanding as of July 31, 2001, as reported by the Issuer in its Form 10-K for the year ended May 31, 2001). - ------ ------------------------------------------------------------------------ CUSIP No. 452526106 13D/A PAGE 3 OF 8 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) Kairos Partners, LP--PN Kairos Partners GP, LLC--OO (limited liability company) Aim High Enterprises, Inc.--CO - ------ ------------------------------------------------------------------------
ITEM 1. SECURITY AND ISSUER: (a) This Amendment No. 7 relates to the common stock, $.10 par value per share, of Immucor, Inc. (the "Common Stock"). (b) The names and addresses of the principal executive officers of the Issuer are as follows: Edward L. Gallup, President and Chief Executive Officer Ralph A. Eatz, Senior Vice President - Operations Dr. Gioacchhino De Chirico, Director of European Operations and President, Immucor Italia S.r.1 Steven C. Ramsey, Vice President - Chief Financial Officer and Secretary Patrick Waddy, President of Dominion Biologicals Limited and European Finance Director Address: c/o Immucor, Inc. 3130 Gateway Drive P.O. Box 5625 Norcross, Georgia 30091 ITEM 2. IDENTITY AND BACKGROUND 1. (a) Kairos Partners, LP, ("Kairos") a limited partnership organized under the laws of the State of Delaware. (b) Address: c/o Aim High Enterprises, Inc. 600 Longwater Drive, Suite 204 Norwell, MA 02061 (c) Principal Business: Investments (d) During the last five years, Kairos has not been convicted in a criminal proceeding. (e) During the last five years, Kairos was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws CUSIP No. 452526106 13D/A PAGE 4 OF 8 2. (a) Kairos Partners GP, LLC, a limited liability corporation organized under the laws of the State of Delaware ("Kairos GP"). Kairos GP is the general partner of Kairos. (b) Address: c/o Aim High Enterprises, Inc. 600 Longwater Drive, Suite 204 Norwell, MA 02061 (c) Principal Business: Investments (d) During the last five years, Kairos GP has not been convicted in a criminal proceeding. (e) During the last five years, Kairos GP was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws 3. (a) Aim High Enterprises, Inc. controls Kairos GP. (b) Address: Aim High Enterprises, Inc. 600 Longwater Drive, Suite 204 Norwell, MA 02061 (c) Principal Business: Investments (d) During the last five years, Aim High Enterprises, Inc. has not been convicted in a criminal proceeding. (e) During the last five years, Aim High Enterprises, Inc. was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Aim High Enterprises, Inc. is a corporation organized under the laws of the State of Delaware. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION: The amount of funds used in acquiring the Common Stock was $3,113,071.96. The source of these funds was Kairos' current cash equivalent assets (working capital). ITEM 4. PURPOSE OF TRANSACTION: At the time that Kairos acquired the shares of Common Stock which are reported hereby, such shares were acquired for investment purposes. Kairos reserves the right from time to time to acquire additional shares, or to dispose of some or all of its shares. CUSIP No. 452526106 13D/A PAGE 5 OF 8 (a) By letter from Kairos to the Issuer, dated September 7, 2001, a copy of which is attached to this Amendment #7 as Exhibit 99.1, John F. White, Principal of Kairos, requested that the Issuer waive the provisions of the Issuer's Shareholder Rights Plan, as amended, to permit Kairos the opportunity to acquire additional shares of Common Stock without triggering the Shareholder Rights Plan. (b) Not applicable (c) Not applicable. (d) Not applicable. (e) Not applicable. (f) Not applicable. (g) Not applicable. (h) Not applicable. (i) Not applicable. (j) Not applicable. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER: (a) The following list sets forth the aggregate number and percentage (based on 7,277,617 shares of Common Stock outstanding as of July 31, 2001, as reported by the Issuer in its Form 10-K for the year ended May 31, 2001) of outstanding shares of Common Stock owned beneficially by each reporting person named in Item 2, as of September 5, 2001:
- -------------------------------- ---------------------------- --------------------------- Name Shares of Common Stock Percentage of Beneficial Beneficially Owned Ownership - -------------------------------- ---------------------------- --------------------------- Kairos Partners, LP 819,770 11.3% - -------------------------------- ---------------------------- --------------------------- Kairos Partners GP, LLC(1) 819,770 11.3% - -------------------------------- ---------------------------- --------------------------- Aim High Partners, Inc.(1) 819,770 11.3% - -------------------------------- ---------------------------- ---------------------------
(1) The reporting person disclaims beneficial ownership of these securities except to the extent of his/its equity interest therein. (b) Kairos has sole power to vote and to dispose of 819,770 shares of Common Stock, representing 11.3% of the outstanding Common Stock. Kairos GP, by virtue of being the general partner of Kairos, may be deemed to have shared power to vote and to dispose of 819,770 shares of Common Stock, representing 11.3% of the outstanding Common Stock. CUSIP No. 452526106 13D/A PAGE 6 OF 8 Aim High Enterprises, Inc., by virtue of its control of Kairos GP, may be deemed to have shared power to vote and to dispose of 819,770 shares of Common Stock, representing 11.3% of the outstanding Common Stock. (c) The following is a description of all transaction in shares of Common Stock of the Issuer by the reporting person identified in Item 2 of this Schedule 13D effected from August 2, 2001 to September 5, 2001: See Appendix A. (d) Not applicable (e) Not applicable ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER : Not applicable. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Exhibit 99.1--Letter to Board of Directors of the Issuer regarding Kairos' request that the Issuer waive the provisions of the Issuer's Shareholder Rights Plan, as amended, to permit Kairos the opportunity to acquire additional shares of Common Stock without triggering the Shareholder Rights Plan. CUSIP No. 452526106 13D/A PAGE 7 OF 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 14, 2001 -------------------------------- (Date) /s/ James F. Rice -------------------------------- (Signature) James F. Rice CUSIP No. 452526106 13D/A PAGE 8 OF 8 Appendix A
- -------------------- ---------------------- ------------------------- ----------------------- Name of Date of Purchase Number of Shares Purchase or Sale Shareholder or Sale Purchased or (Sold) Price Per Share - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/2/01 1,000 $3.89 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/2/01 1,000 $3.83 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/2/01 1,000 $3.81 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/2/01 500 $3.93 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/2/01 500 $3.91 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/2/01 300 $3.88 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/3/01 1,000 $3.86 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/3/01 1,000 $3.86 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/3/01 500 $3.88 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/3/01 500 $3.83 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/8/01 2,500 $3.36 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/8/01 1,000 $3.47 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/8/01 1,000 $3.47 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/8/01 400 $3.69 - -------------------- ---------------------- ------------------------- ----------------------- Karios 8/9/01 800 $3.29 - -------------------- ---------------------- ------------------------- ----------------------- Karios 8/9/01 500 $3.38 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/9/01 100 $3.64 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 8/9/01 100 $3.45 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/4/01 8,300 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/4/01 5,000 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/4/01 5,000 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/4/01 4,300 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/4/01 4,000 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/4/01 2,700 $2.630 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/4/01 2,100 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Karios 9/4/01 1,000 $2.764 - -------------------- ---------------------- ------------------------- ----------------------- Karios 9/4/01 1,000 $2.674 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 5,000 $2.670 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 5,000 $2.610 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 5,000 $2,600 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 5,000 $2,600 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 4,000 $2,670 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 4,000 $2.610 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 3,500 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 3,000 $2.710 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 2,000 $2.670 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 2,000 $2.670 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 1,500 $2.670 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 1,500 $2.670 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 1,500 $2.610 - -------------------- ---------------------- ------------------------- ----------------------- Kairos 9/5/01 1,000 $2.674 - -------------------- ---------------------- ------------------------- -----------------------
The shares of Common Stock were purchased by Kairos in the over-the-counter market. EX-99.1 3 a1036747.txt LETTER Exhibit 99.1 September 7, 2001 Mr. Edward L. Gallup Chairman Immucor Inc. 3130 Gateway Drive Norcross, GA 30091-5625 Dear Mr. Gallup, As you know, Kairos Partners, L.P. has been a shareholder of Immucor since September 2000. Since that time, Kairos has continued to increase its ownership position in Immucor to over 11% and is now Immucor's largest shareholder. Our increasing ownership clearly demonstrates that Kairos remains positive about the long-term potential for Immucor. Kairos believes that the strongest way to demonstrate that belief to our fellow shareholders is to continue to accumulate stock in Immucor. However, the Company has implemented a Shareholder Rights Agreement that prevents an interested existing shareholder to hold an ownership position greater than 15% of the Company's stock. Under this Shareholder Rights Agreement, the Board of Directors may approve an ownership position greater than 15%. As such, Kairos Partners, L.P. formally submits this request to the Board of Directors to waive those provisions contained within the Shareholder Rights Agreement, dated as of April 16, 1999, as amended by Amendment No. 1 to Shareholder Rights Agreement, effective as of November 29, 2000 to allow Kairos the opportunity to acquire up to 25% of the Company's stock. We believe that the involvement of a significant and interested shareholder, with the industry experience of Kairos Partners, L.P., would be in the best interest of all shareholders of Immucor. The approval of this request by the Board would demonstrate to all its shareholders the Company's willingness and desire to work with a shareholder committed to investing substantial capital and committed to the long-term best interests of our fellow shareholders. I would appreciate a response to this request by Friday, September 14, 2001. Sincerely, John F. White Kairos Partners, L.P. JFW/srh cc: D. Lanson / D. Smith /R. Eatz / B. Papesh / J. Rosen / G. De Chirico / D. McKeithan -----END PRIVACY-ENHANCED MESSAGE-----